Clinical Trials

Clinical Trial
  • Status: Not yet recruiting
  • Intervention Type: Device
  • Participants: 100
  • Start Date: March 1, 2021
High-definition Videobronchoscopy With Optical Enhancement for the Diagnosis of Endobronchial Sarcoidosis: a Pilot Study
Clinical Trial
  • Status: Not yet recruiting
  • Intervention Type: Diagnostic Test
  • Participants: 100
  • Start Date: February 1, 2021
Evaluation of Diagnostic Criteria in Cardiac Sarcoidosis - an Observational Study
Search for trials
Clinical Trial
  • Status: Recruiting
  • Intervention Type: Genetic
  • Participants: 40
  • Start Date: December 1, 2020
Genetic Predisposition to Severe Forms of COVID-19 (SARS-CoV2 Infection) in Patients Without Comorbidities
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 2
  • Intervention Type: Drug
  • Participants: 28
  • Start Date: October 23, 2020
Interleukin-1 Blockade for Treatment of Cardiac Sarcoidosis
Clinical Trial
  • Status: Not yet recruiting
  • Phase: Phase 4
  • Intervention Type: Drug
  • Participants: 14
  • Start Date: October 2020
Use of CXCL9 as a Biomarker of Acthar Efficacy
Clinical Trial
  • Status: Not yet recruiting
  • Intervention Type: Procedure
  • Participants: 60
  • Start Date: September 1, 2020
Development of Airway Absorption Sampling Methods for Biomarker Assessment in Probable Idiopathic Pulmonary Fibrosis (IPF) Patients
Clinical Trial
  • Status: Recruiting
  • Participants: 5000
  • Start Date: August 4, 2020
Rheumatology Patient Registry and Biorepository
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 4
  • Intervention Type: Drug
  • Participants: 138
  • Start Date: June 1, 2020
The PREDMETH Trial: Effectiveness of Methotrexate Versus Prednisolone as First-line Therapy for Pulmonary Sarcoidosis - A Randomized Controlled Trial
Clinical Trial
  • Status: Recruiting
  • Intervention Type: Diagnostic Test
  • Participants: 200
  • Start Date: June 1, 2020
Serologic Profile of SARS CoV2 in COVID-19 Patients With Systemic Diseases
Showing 1-12 of 59